جستجوی استاد راهنمای دانشگاهی

Michael Yeager, PhD, serves as an Associate Clinical Professor in the School of Medicine at the University of Colorado Denver, focusing on cardiopulmonary pathophysiology with emphasis on pulmonary hypertension and heart failure mechanisms. He completed his PhD at the University of Colorado Health Sciences Center in 2002, establishing foundational expertise in vascular biology. His research program investigates immunological and molecular drivers of pulmonary vascular disease, particularly the roles of autoantibodies, fibrocytes, and inflammatory cascades in disease progression. Analysis of his 14 publications (2012-2015) reveals consistent exploration of biomarker discovery, vascular remodeling, and immune dysregulation across pediatric and adult pulmonary hypertension. Key methodological approaches include proteomics, animal modeling, and molecular interrogation of cellular stress responses, with significant translational implications for personalized therapeutic strategies. Professional recognitions include: Outstanding Faculty award from Tau Beta Pi (2019) Chancellor's Teaching Recognition Award from the University of Colorado (2016) Dr. Yeager maintains active clinical research collaborations at Children's Hospital Colorado while mentoring within the medical school curriculum. His work bridges basic science discovery with clinical application through ongoing investigations into endothelial dysfunction and inflammatory mediators. Affiliated with the Department of Medicine, he contributes to pulmonary vascular research initiatives and participates in professional societies including the American Thoracic Society, American Heart Association, and T21 Research Society.

• Pulmonary vasculature
• Heart Failure
• Cardiopulmonary Immunology

Robert Camp is a Researcher at Yale School of Medicine , affiliated with the Department of Pathology . His work focuses on biomarkers , quantitative analysis , and automation in pathology . Education MD, Yale University School of Medicine (1997) PhD, Yale University School of Medicine, Immunology (1992) BA, Swarthmore College, Biology (1987) His research interests include tumor microenvironment , biomarker quantification , and histopathology standardization , with a focus on renal cell carcinoma and interstitial lung disease . Recent publications highlight automation tools like the AQUA System and X-Tile software for tumor subpopulation analysis . Scientific contributions include the Charles W. Bomfalk Prize for medical student teaching and leadership in the Breast Cancer Alliance . He has collaborated extensively with researchers such as David Rimm and Harriet Kluger on projects involving tumor vascularity and immunotherapy targets .

• Biomarkers
• Quantitative Analysis in Pathology
• Medical Data Interpretation
• +۵ مورد دیگر

Thomas J. Marini, M.D. , is an Assistant Professor in the Department of Imaging Sciences at the University of Rochester Medical Center. He specializes in diagnostic radiology and neuroradiology, with a focus on expanding imaging access through teleultrasound and AI integration. Education M.D., University of Rochester, 2017 Internship, Transitional Year, St. Josephs Hospital and Health Center, 2017–2018 Residency, Diagnostic Radiology, University of Rochester Medical Center, 2018–2022 Fellowship, Neuroradiology, University of Rochester Medical Center, 2022–2023 Research Interests Dr. Marini’s research spans medical imaging , artificial intelligence , and telemedicine , particularly in low-resource settings. His recent work explores AI-driven ultrasound segmentation, pulmonary vasculature imaging, and telediagnostic systems for obstetrics, thyroid, and breast imaging. His publications highlight AI integration in ultrasound, automated fetal biometry , and imaging accessibility improvements in rural Peru. This aligns with his focus on democratizing diagnostic tools through technology. Scientific Awards Best Fellow Teacher Award, 2023 Cum Laude Award (American Society of Pediatrics), 2022 University of Rochester Imaging Sciences Excellence Award, 2022 Roentgen Research Award, 2022 Holman Research Pathway Certificate, 2022 Phi Beta Kappa Honor Society Induction, 2013

• Medical Imaging
• Neuroradiology
• Artificial Intelligence in Radiology
• +۵ مورد دیگر

Adam Goodwill, Ph.D., FCVS is an Assistant Professor in the Department of Integrative Medical Sciences at Northeast Ohio Medical University (NEOMED). He previously served as Assistant Clinical Professor of Anatomy, Cell Biology & Physiology and Director of the Pre-Professional M.S. Program at Indiana University School of Medicine for a decade before relocating to Northeast Ohio in 2021. Ph.D. in Physiology and Pharmacology, West Virginia University School of Medicine (2011) B.S. in Molecular Biology/Biotechnology, Clarion University of Pennsylvania (2003) B.S. in Biology, Clarion University of Pennsylvania (2003) His research focuses on the interplay between myocardial contractile function and coronary blood flow regulation, particularly how oxygen demand and delivery become dysregulated in cardiovascular diseases. The laboratory employs a top-down approach, starting with in vivo models and progressing to molecular analysis, aiming to identify therapeutic targets for cardiovascular disorders. Key research themes from his publications include: Investigation of sodium-glucose cotransporter-2 inhibition in myocardial ischemia GLP-1 receptor activation effects on cardiac efficiency in obese models Role of KV1 channels in coronary blood flow regulation Adipose tissue dysfunction in disease pathogenesis Scientific recognitions include awards from the American Physiological Society (Teaching and Cardiovascular Sections) and the Society for Experimental Biology and Medicine's Burton E. Sobel Award. He has presented at major conferences including Experimental Biology, Korean Society of Heart Failure, and American Heart Association Scientific Sessions. Dr. Goodwill serves on editorial boards for Frontiers in Cardiovascular Therapeutics and Scientific Reports , and teaches courses in Cardiovascular, Pulmonary and Renal (CPR) systems as well as Gastrointestinal-Reproductive-Endocrine (GRE) systems at NEOMED.

• Cardiovascular Physiology
• Coronary Circulation
• Myocardial Function
• +۲ مورد دیگر

Swapnil Sonkusare is a Professor in the Department of Molecular Physiology and Biological Physics at the University of Virginia School of Medicine and the Director of Graduate Studies in Physiology. His research focuses on calcium signaling mechanisms in vascular function and dysfunction, particularly in hypertension, obesity, pulmonary hypertension, and atherosclerosis. He leads the Sonkusare Laboratory at the Robert M. Berne Cardiovascular Research Center. Key Research Areas: Biophysics, Cardiovascular Biology, Physiology, Calcium Signaling, TRP Channels. Techniques: Transgenic mouse models, high-speed confocal imaging, patch-clamp electrophysiology, dSTORM super-resolution imaging. Sonkusare’s lab investigates how TRP ion channels interact with other signaling proteins to regulate blood pressure and vascular tone. His work has identified novel calcium signaling nanodomains in smooth muscle cells and elucidated the role of endothelial TRPV4 channels in pulmonary hypertension and obesity-induced hypertension. His lab’s recent publications highlight discoveries in mechanosensitive signaling , purinergic-TRPV4 pathways , and oxidative stress in vascular dysfunction . Collaborative studies with Dr. Venetia Laubach on lung ischemia-reperfusion injury have been featured in Science Signaling and Circulation . Scientific Awards: Mid-Career Award in Cardiovascular Pharmacology (ASPET, 2022). Dean’s Excellence in Faculty Research Award (UVA, 2022). Grants: Multiple NIH R01 grants (HL167208, HL142808, HL146914, EY034238, HL157407) fund his work on TRPV4 signaling, calcium nanodomains, and vascular inflammation. Labs & Teams: Based at the Robert M. Berne Cardiovascular Research Center, his lab collaborates with institutions like Johns Hopkins, McGill University, and the University of Maryland. Current members include Research Scientists Yen-Lin Chen and Maniselvan Kuppusamy, with former students Matteo Ottolini (now at Bayer Oncology) and Corina Marziano (Analytical Scientist at Medpace).

• Biophysics
• Cardiovascular Biology
• Physiology
• +۲ مورد دیگر

Dr. Ari Molofsky is an Associate Professor in the Department of Laboratory Medicine at the University of California, San Francisco (UCSF) School of Medicine. Trained as an MD/PhD with clinical specialization in hematopathology, he leads a basic research laboratory focused on the intersection of immunology and tissue homeostasis. Dr. Molofsky is also an affiliate member of multiple UCSF programs including Microbiology and Immunology, ImmunoX Program, Liver Center, Pulmonary Research Group, NeuroImmunology Center for Excellence, and the UCSF Diabetes Center. Education: BS in Molecular Biology, University of Texas, Austin (1999) PhD in Immunology & Microbiology, University of Michigan, Ann Arbor (2007) MD, University of Michigan, Ann Arbor (2007) Residency/Fellowship in Clinical Pathology / Hematopathology, UCSF (2011) Dr. Molofsky's research focuses on stromal-immune niches across multiple organ systems including brain, lung, liver, adipose tissue, skin, and intestine. His work centers on type 2 immunity, innate lymphoid cells, regulatory T cells, and cytokine signaling (particularly Interleukin-33 and Interleukin-5). His laboratory investigates how immune cells interact with tissue microenvironments to maintain homeostasis and how dysregulation contributes to diseases like obesity, type 2 diabetes, and inflammatory conditions. Using foundation models, his team studies organ development, remodeling, and the role of fibroblasts and tissue-resident lymphocytes in health and disease. Dr. Molofsky's recent publications demonstrate a strong focus on neuroimmunology, particularly the role of immune cells in brain development and function, alongside ongoing work in pulmonary immunology, liver fibrosis, and adipose tissue immunometabolism. His research increasingly explores the intersection between the nervous and immune systems, with several high-impact publications on how immune cells shape neural circuits and behavior. Scientific Awards: Clarivate 2022 Most Highly Cited Researchers (top 1%) UCSF 2021 Medical School Foundations Curriculum Teaching Award AAI 2019 American Association of Immunology Travel Award UCSF 2019 Nina Ireland Program for Lung Health Award Multiple early-career awards including NIH K08 and Hillblom Foundation Young Investigator Award As a mentor, Dr. Molofsky has guided graduate students, post-doctoral fellows, and junior faculty, emphasizing the balance between clinical and research work. His laboratory is supported by multiple NIH R01 grants including projects on meningeal type 2 immunity in brain development, macrophage-fibroblast interactions in lung fibrosis, and the IL-33/ILC2 axis in various tissue contexts. He also holds funding from the California TRDRP and the Larry L. Hillblom Foundation. Dr. Molofsky's laboratory maintains active collaborations across UCSF, particularly with the NeuroImmunology Center for Excellence and the Pulmonary Research Group. His team utilizes advanced techniques including flow cytometry, tissue clearing, and imaging to study immune-stromal interactions in diverse tissue contexts.

• Immunology
• Type 2 Immunity
• Innate Lymphoid Cells
• +۷ مورد دیگر

LeeAnn Higgins is a Researcher at the Center for Metabolomics and Proteomics at the University of Minnesota. With over 25 years of research activity (since 1995), her work spans proteomics, mass spectrometry, and host-microbe interactions, particularly in clinical contexts like cystic fibrosis and pulmonary hypertension. Key research areas: Ferroptosis, SERPINE1 gene mutations, and aerolysin-based nanobody engineering Recent collaborations focus on metaproteomics workflows and cystic fibrosis disease modeling Contributions to UN Sustainable Development Goals through biomedical research Selected publications demonstrate expertise in: 2025: Ferroptosis inhibition mechanisms in cardiac function 2025: SERPINE1 mutation analysis in canine models 2024: Notch signaling inhibition using pore-forming toxins 2024: Ferroptosis-driven inflammation in pulmonary hypertension 2022: Optimized proteomics workflows for bronchoalveolar lavage fluid Research trends show integration of: Mass spectrometry techniques Metaproteomics for host-microbe dynamics Translational approaches across veterinary and human medicine Contact: higgi022@umn.edu

• Proteomics
• Mass Spectrometry
• Metatranscriptomics
• +۵ مورد دیگر

Susan K. Hobbs, MD, PhD is a Professor at the University of Rochester Medical Center (URMC) within the Department of Imaging Sciences and Associate Dean for Equity and Inclusion in the School of Medicine and Dentistry. She specializes in cardiothoracic imaging and resident education. Harvard Medical School (MD) Massachusetts Institute of Technology (PhD in Chemical Engineering) Undergraduate in Chemical Engineering from University of Minnesota Her research focuses on tumor angiogenesis, novel imaging biomarkers, and diagnostic imaging applications in pulmonary diseases, oncologic thoracic processes, cardiovascular disease, and parathyroid disorders. She has pioneered programs in Cardiac MRI and Lung Cancer Screening at URMC. Dr. Hobbs' publications highlight expertise in chest imaging , CT methodology , tumor proteomics , and radiologic education . Key contributions include bone suppression techniques, pulmonary artery imaging, and image-guided proteomic analysis. Best Conference Teachers Award (2015) Arvin Robinson Teaching Award (2014-2015) TAVI Team Service Excellence Award (2014) NIH Fellowships (1994-1998) AACR Scholarships (1997-1998) Dr. Hobbs actively contributes to resident education and serves on multiple professional societies including the Society of Thoracic Radiology and RSNA. She acts as a reviewer for NIH and Radiology journal.

• Diagnostic Imaging
• Cardiothoracic Imaging
• Tumor Angiogenesis
• +۵ مورد دیگر

Mark Mondrinos is an Assistant Professor of Biomedical Engineering at Tulane University, affiliated with the School of Science & Engineering. His research focuses on developing microphysiological systems and organoid-based models to study human tissues and diseases, with a particular emphasis on lung, muscle, and interstitial tissues. He integrates confocal microscopy and biochemical analysis to bridge translational gaps in preclinical therapy screening. Academic roles include teaching courses such as Microphysiological Systems (BMEN 6440) and Quantitative Physiology (BMEN 3070/6070). Education & Affiliations: Inaugural Fellow, Center for Engineering Mechanobiology at Penn (2017) Postdoctoral Fellow in Bioengineering, University of Pennsylvania (2014–2016) Postdoctoral Fellow, Temple University School of Medicine (2012–2014) Ph.D. in Biomedical Engineering, Drexel University (2011) B.Sc. Chemical Engineering & Biological Chemistry, Florida State University (2002) Research Focus: His lab engineers biologically-inspired models to study respiratory exposure injuries (e.g., vaping), fibrotic disorders, and muscle injury. Current projects include multi-organ microfluidic models for systemic effects of malignancies like cachexia. Key tools include organ-on-a-chip platforms and advanced imaging techniques. Publications: Recent work spans PKC-delta inhibition in sepsis, tumor microenvironment modeling, and vascularized lung scaffolds. These studies highlight translational applications in drug screening and disease mechanisms. Awards: 2013 Jeanette Piperno Memorial Award 2011 Drexel University Best PhD Dissertation Labs/Teams: His laboratory at Tulane specializes in tissue engineering and microphysiological systems, collaborating with institutions like the University of Pennsylvania's Mechanobiology Center. Ongoing projects aim to advance personalized medicine through organ-on-a-chip technologies.

• Biomedical Engineering
• Tissue Engineering
• Microphysiological Systems
• +۵ مورد دیگر

Fiona Britton is Chair and Professor of Biomedical Sciences in the School of Dental Medicine at the University of Nevada, Las Vegas (UNLV). Holding a B.Sc. and Ph.D. from Ulster University, Northern Ireland, she has built an internationally recognized research program focused on ion-channel physiology, smooth-muscle excitability, and cardiovascular regulation. Education Ph.D., Ulster University, Northern Ireland B.Sc., Ulster University, Northern Ireland Research Focus Professor Britton’s work centers on the molecular and functional characterisation of calcium-activated chloride channels (CaCCs), bestrophins, anoctamins/TMEM16, TRPV channels, and voltage-gated calcium channels. Using patch-clamp electrophysiology, molecular biology, and transgenic models, her group investigates how these channels control arterial tone, cardiac pacemaking, gastrointestinal motility, and uterine blood flow. A recurring theme is the integration of ion-channel activity with intracellular Ca²⁺ handling, offering insights into hypertension, heart failure, and pregnancy-related vascular adaptation. Across more than 40 peer-reviewed publications spanning 1997-2021, her studies trace an arc from cloning and expression of cardiac chloride channels (ClC-2, ClC-3, bestrophins) to demonstrating their physiological impact in smooth-muscle organs. Recent work has illuminated β-adrenoceptor subtype pharmacology in cremaster arterioles and TRPV3-mediated vasodilation in uterine vasculature, underscoring translational relevance to reproductive and cardiovascular medicine. Contact Email: fiona.britton@unlv.edu Phone: 702-774-8680 Mail Code: 7412, University of Nevada, Las Vegas

• Ion-channel physiology
• Cardiovascular electrophysiology
• Smooth-muscle excitability
• +۴ مورد دیگر

Dr. Michael Lee is an Assistant Professor of Medicine in the School of Medicine at the University of California, San Francisco (UCSF), specializing in pulmonary vascular diseases with a particular focus on pulmonary hypertension related to schistosomiasis and connective tissue disorders. His research integrates metabolomics, immunology, and vascular biology to uncover disease mechanisms and identify novel therapeutic targets. Dr. Lee completed his medical training at New York University, earning his MD in 2013, followed by Internal Medicine Residency (2016) and service as Chief Resident (2017). He further specialized through a Pulmonary Sciences and Critical Care Medicine Fellowship at the University of Colorado, completed in 2020. His research program centers on the metabolic underpinnings of pulmonary hypertension, with significant contributions to understanding the roles of macrophages, T cells, and metabolic dysregulation in disease pathogenesis. Dr. Lee's work has established important connections between parasitic infections, autoimmune disorders, and pulmonary vascular pathology, with increasing emphasis on metabolomics approaches to study transpulmonary gradients and cellular metabolism. Analysis of Dr. Lee's publication record reveals a sophisticated research trajectory focused on the intersection of pulmonary hypertension with infectious diseases (particularly schistosomiasis), connective tissue disorders, and metabolic pathways. His recent work demonstrates methodological sophistication through metabolomics integration and has expanded into exercise physiology applications and novel therapeutic approaches for pulmonary hypertension. Fulbright U.S. Scholar (2022-2023) NIH K08 Career Development Award recipient (2023-2028) U.S. Department of Defense grant recipient (2022-2025) CHEST Foundation Research Grant recipient (2021-2022) Dr. Lee serves as Principal Investigator on multiple significant research projects totaling millions in funding. His NIH K08 award investigates hypoxia inducible factor-1-dependent glycolysis in lung interstitial macrophages related to schistosomiasis-induced pulmonary hypertension. He also leads a Fulbright U.S. Scholar project on transpulmonary metabolomics in systemic sclerosis-associated pulmonary arterial hypertension and a Department of Defense project examining dysregulated pulmonary vascular metabolism. His research has established important connections between parasitic infections, autoimmune disorders, and pulmonary vascular disease. Dr. Lee collaborates extensively with the Graham laboratory at UCSF and maintains international research partnerships in Ethiopia and Zambia studying schistosomiasis-associated pulmonary hypertension. His work involves multidisciplinary teams including immunologists, metabolomics specialists, and clinicians specializing in pulmonary vascular diseases. He is actively involved in the Division of Pulmonary and Critical Care Medicine at UCSF, contributing to both clinical care and research initiatives focused on rare pulmonary vascular disorders.

• Pulmonary Hypertension
• Schistosomiasis
• Pulmonary Vascular Disease
• +۵ مورد دیگر

Inderjit Singh, MBChB, is an Associate Professor at Yale School of Medicine, specializing in Pulmonary, Critical Care & Sleep Medicine. He serves as the Director of the Pulmonary Vascular Disease Program and Program Director for the Advanced Fellowship in Pulmonary Vascular Disease. Dr. Singh is a specialist in pulmonary hypertension (high blood pressure in the heart-to-lung system) and leads one of the few centers worldwide that performs invasive cardiopulmonary exercise testing (iCPET) for patients with unexplained shortness of breath or fatigue. Dr. Singh's educational background includes: Fellow, Pulmonary Vascular at Brigham and Women's Hospital (2018) Fellow, Pulmonary & Critical Care at New York Presbyterian - Weill Cornell Medical Center (2016) Residency in Internal Medicine at University of Pennsylvania (2013) Internship in Internal Medicine at University of Pennsylvania (2011) Residency and Internship in Internal Medicine at Beaumont Hospital, Dublin, Ireland (2010, 2008) MBChB and BMedSci from Royal College of Surgeons in Ireland (2007) Dr. Singh's research focuses on understanding how the right ventricle of the heart and pulmonary circulation interact, particularly during exercise. His work explores the pathophysiology of pulmonary hypertension, with emphasis on exercise-induced abnormalities and the mechanisms underlying long COVID-related exercise intolerance. He has developed expertise in invasive cardiopulmonary exercise testing (iCPET), which allows for detailed hemodynamic assessment during physical exertion. His research has significant implications for understanding cardiopulmonary function in health and disease, particularly in conditions like pulmonary hypertension, heart failure, and post-COVID syndrome. Dr. Singh's recent publications demonstrate a strong focus on pulmonary vascular mechanics, right heart function, and the application of advanced imaging and physiological testing methods. His work spans basic science investigations of pulmonary artery structure and function to clinical studies of cardiopulmonary exercise testing in various disease states. A notable theme is the investigation of how the proximal pulmonary artery regulates cardiopulmonary function, with particular attention to age-related changes and disease processes. His research integrates physiological measurements with advanced imaging techniques to provide comprehensive insights into cardiopulmonary pathophysiology. Dr. Singh has received several prestigious awards for his work: Bronze award from Society of Critical Care Medicine (2024) Best abstract award from Society of Cardiovascular Anesthesiologists (2023) Best poster award from National Older Americans Independence Center (2023) Nomination for the Charles W. Bohmfalk Prize for teaching (2022) Best abstract award from Society of Cardiovascular Anesthesiologists (2022) Dr. Singh is actively involved in clinical research, serving as a sub-investigator for multiple clinical trials including studies on pulmonary hypertension treatments. He is a dedicated educator who directs fellowship programs and mentors trainees in pulmonary vascular medicine. His laboratory work focuses on understanding the biomechanical properties of the pulmonary vasculature and their implications for cardiopulmonary function. Dr. Singh leads the Pulmonary Vascular Disease Program at Yale, which focuses on the diagnosis and treatment of pulmonary hypertension and related conditions. The program performs specialized testing including invasive cardiopulmonary exercise testing, which is rare among medical centers worldwide. His team collaborates closely with experts in cardiology, radiology, and basic science to advance understanding of pulmonary vascular diseases.

• Pulmonary Hypertension
• Right Heart Function
• Cardiopulmonary Exercise Testing
• +۴ مورد دیگر

Magdalena Karbowniczek, PhD is a Professor at Texas Tech University Health Sciences Center (TTUHSC) in the School of Pharmacy's Department of Immunotherapeutics & Biotechnology. She holds both an MD (1993) and PhD in tumor pathology (1998) from Pomeranian Medical University in Poland. Dr. Karbowniczek is board certified in Anatomic Pathology and served as a histopathology consultant prior to coming to the USA. She completed postdoctoral training in Dr. Elizabeth Henske's laboratory at the Fox Chase Cancer Center, Philadelphia. Dr. Karbowniczek's research focuses on understanding the molecular mechanisms of Tuberous Sclerosis Complex (TSC), Notch signaling, cell fate decisions, tumor suppressor genes, and cancer development. Her laboratory investigates how cell proteins and genes interact during embryonic development and later in life to transform normal cells into cancer cells. She employs syngeneic and genetically modified mouse models, drugs targeting downstream effectors, and advanced techniques including fluorescent-activating cell sorting, digital pathology, and various molecular biology assays. Analysis of her publication record shows consistent research output spanning two decades with a recent acceleration in productivity. Her work bridges cancer biology, immunology, and molecular signaling pathways, with particular emphasis on how tumor suppressor genes like those involved in TSC contribute to cancer initiation and progression. The majority of her publications involve collaborations with Markiewski MM, Henske EP, and other researchers in the field. Dr. Karbowniczek has mentored graduate students through laboratory rotations and continues to accept motivated students interested in tumor cell biology and cancer progression research. Her work has significant implications for understanding common human cancers including melanoma, brain tumors, and lung cancer through the study of rare TSC-related malignancies.

• Cancer Biology
• Tuberous Sclerosis Complex
• Molecular Oncology
• +۵ مورد دیگر

Michal J. Cidon is a Clinical Assistant Professor of Pediatrics at the Keck School of Medicine, University of Southern California. His clinical and research expertise bridges pediatric rheumatology and pulmonology, focusing on interstitial lung disease, autoimmune disorders, and systemic inflammatory conditions. Key research areas: Pediatric Rheumatology, Pulmonary Fibrosis, Medical Education, and Clinical Trials Prominent work includes studies on juvenile dermatomyositis, biologic therapies for autoimmune diseases, and ventilation-perfusion mismatches in respiratory illnesses Recent publications highlight advancements in understanding rare lung diseases and improving fellowship training through competency milestones

• Pediatric Rheumatology
• Interstitial Lung Disease
• Pulmonary Fibrosis
• +۳ مورد دیگر

George F. Rich is the Harrison Medical Teaching Professor and Chair of the Department of Anesthesiology at the University of Virginia School of Medicine. He also holds a professorship in the Department of Biomedical Engineering, reflecting his interdisciplinary expertise. His clinical and research leadership is central to the department's mission in education, patient care, and research. Dr. Rich earned his B.S. in Mechanical Engineering, M.D., and Ph.D. in Bioengineering, all from the University of Utah. This unique combination of training underpins his research at the intersection of engineering and medicine. His research focuses on cardiovascular engineering, particularly the role of endothelial pathways in vascular regulation. Key areas include the nitric oxide/guanylate cyclase system, inhaled nitric oxide therapy for pulmonary hypertension, and vascular dysfunction in sepsis. Using chronic hypoxia rat models and isolated organ systems, his lab investigates both acute and long-term vascular responses with direct clinical relevance. His recent publications reveal a consistent focus on nitric oxide signaling, pulmonary vasoconstriction, and inflammatory modulation in animal models. The work spans physiology, pharmacology, and critical care, demonstrating translational impact. Effects of anesthesia on endothelium and vascular smooth muscle Dr. Rich leads significant research initiatives funded by grants related to vascular function and anesthesia. While specific students are not listed, his role as a professor and research leader implies active mentorship of trainees and junior scientists. He also contributes to medical education as a named teaching professor. His laboratory work involves integrated physiological models including isolated lung and kidney preparations, complemented by molecular techniques such as western blotting, light microscopy, and radioimmunoassays, forming a comprehensive approach to studying vascular tone and endothelial health.

• Cardiovascular Engineering
• Anesthesiology
• Biomedical Engineering
• +۷ مورد دیگر